Know your enemy...
“ If you know the ene my
(SARS-Cov-1, MERS, SARS-Cov-2)
and know Yourself,
you need not fear the result
of a hundred battles.
If you kn ow Yourself,
but not the enemy
(SARS-Cov-1, MERS, SARS-Cov-2),
than for every victory gained
you will also suffer a defeat.
If You know neither the enemy
(SARS-Cov-1, MERS, SARS-Cov-2),
nor Yourself,
than You will succumb
in every battle.”
'The Art of War' - Sun Tzu
When I was in the Military during 911...
When I was in the Military during 911, individuals (domestic) started to intentionally distribute mysterious "White Powder" - to simulate the appearance of Anthrax in government buildings, businesses, USPS, etc. Because of the severity of the threat and financial disruptions, the rapid detection and delineation to determine if any mysterious "White Powder" was Anthrax or a fake substance became one of the US's highest priorities.
Because of my prior medical experience working with lab animals, medical techniques, lab equipment/testing, pathogens, and Zoonotic diseases, I was able within the span of a few days, to Research and Developed the world's first rapid Weapons Grade Anthrax - (Bacillus anthracis) spores test (using existing technologies). ( Circa 2001-2002) ...
Between 2013 and 2016, I engaged in the meticulous review of "data sets" derived from research papers on Mice, Ferrets, and Rhesus macaques. My goal was to assess their exposure to various viral loads, including different strains, variants, deviations, and genomic compositions, as well as pathogenic lineages. Furthermore, from 2016 to 2017, I followed researchers in China, shadowing their quest to locate and capture Horseshoe bats. The purpose was to gather their genomes and track and trace the reservoirs of viruses in China, while also uncovering new associations and "data sets" to evolutionary changes within those strains.
This was an aerosolization test (Sept 2020), using engineered 15 micron Laser Reflective Particles -
15 microns is equal to 150 CoViD-19 stuck together,
which easily stayed suspended and floated in the air for over 6 hrs+.
In November 2019, upon learning of a potential contagious pneumonia outbreak in China, I immediately embarked on collecting data and conducting quantitative research. My goal was to uncover the various variables, factors, and potential spread of this airborne pathogen through person-to-person transmission.
By March 2020, I had completed my comprehensive analysis, encompassing statistical probabilities, mitigation strategies, and threat assessments. Advancements in technology since the SARS-Cov-1 outbreak in 2002-2003 provided me with access to new data sets and genome sequencing specifically related to COVID-19/SARS-Cov-2. Leveraging this invaluable live digital data, I utilized genome tracking techniques to study deviations, mutations, and variables affecting mitigation efforts. This groundbreaking approach allowed me to develop algorithms capable of calculating the percentage of "asymptomatic" individuals within a given population, forming a vital component in understanding the dynamics of the virus within a community
